Report cover image

Global Markets for Generic Drugs

Publisher BCC Research
Published Jan 15, 2024
Length 126 Pages
SKU # WA18451666

Description

Global Markets for Generic Drugs



Report Scope:

The report discusses the current size and growth of the market for generic drugs, both in global terms and broken down by the most important national markets. The report covers small molecule drugs and biosimilars. It includes market drivers and challenges in the generic drug industry. The competitive landscape includes generic drug sales of key competitors and their ranking in the market. It also covers the emerging trends in the generic drugs industry.

By geographical region, the market has been segregated into North America, Europe, Asia-Pacific, and the Rest of the World. The North America region includes countries such as the U.S., Canada and Mexico; Europe includes Germany, U.K., Italy, and Rest of Europe; Asia-Pacific includes China, India, Japan, and Rest of Asia-Pacific. The estimated values used are based on drug manufacturers’ total revenues.

Report Includes:

37 data tables and 39 additional tables

An overview of the global markets for generic (pharmaceutical) drugs

Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028

Estimate of the market size and revenue forecast of the market for generic drugs, and corresponding market share analysis based on molecule type and geographic region

Evaluation of the current and future market potential of generic drugs, as well as the major generics, regulatory landscape and patent cliff within the biopharmaceutical industry

Discussion of the major market drivers, opportunities and challenges, emerging technologies, and regulations

Data and market value analyses for the U.S., Canada, Mexico, Germany, the U.K., Italy, China, India and Japan

Overview of the sustainability trends and factors in the market for generic drugs, with emphasis on consumer attitudes, ESG scores, case studies and the ESG practices of leading companies

Analysis of the pipeline for new generic drugs and their impact on the growth of the overall biopharmaceutical products market

Patent review and analysis of key patent grants

An analysis of the industry structure, including company market shares, recent M&A activity, and venture funding

Analysis of the top market players, their global rankings, recent developments, key financials and segmental revenues, and product portfolios

Profiles of the leading market players

Companies Mentioned

ASPEN PHARMACARE
AUROBINDO PHARMA
CIPLA INC.
DR. REDDY'S LABORATORIES LTD.
FRESENIUS KABI
LUPIN LTD.
SANDOZ
SUN PHARMACEUTICAL INDUSTRIES LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
VIATRIS INC."

Table of Contents

126 Pages
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update?
Research Methodology
Information Sources
Regional Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Market Overview
Introduction
Adequate Market Size
Patent-Expired Therapies
Older Products Still Used
Long-Term Use
Straightforward Production Technology
Drugs Used in Primary Care
Biosimilars
Chapter 4 Market Dynamics
Market Drivers
Increasing Patent Cliffs and Loss of Exclusivities
Favorable Healthcare Policies
Changing Physician Attitudes
Market Challenges
Pricing Pressures and Low Profit Margins
Patent Extension Strategies of Innovator Companies
Chapter 5 Market Breakdown by Molecule Type
Global Market for Generic Drugs
Global Generic Drugs Market, by Molecule Type
Small Molecule Generics
Biosimilars
Chapter 6 Market Breakdown by Region
Introduction
North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Chapter 7 Sustainability: An ESG Perspective
Introduction to ESG
Sustainability in the Generic Drugs Industry: An ESG Perspective
Key ESG Issues
Environmental Performance of Key Generic Drug Companies
Social Performance of Key Generic Drug Companies
Governance Performance of Key Generic Drug Companies
Case Study
Concluding Remarks from BCC
Chapter 8 Emerging Trends and Developments
Key Trends in the Market
Collaborations for R&D
Rise of Complex Generics in Immunology and Oncology
Improving Portfolio Efficiency
Focus on Emerging Markets
Chapter 9 Regulatory Landscape
Regulatory Overview
U.S.
Evolving Situation in the U.S.
European Union
Japan
Regulation of Biosimilars
EU Provisions
Authorized Generic Drugs
Chapter 10 Competitive Landscape
Competitive Landscape
M&A Analysis
Chapter 11 Company Profiles
ASPEN PHARMACARE
AUROBINDO PHARMA
CIPLA INC.
DR. REDDY'S LABORATORIES LTD.
FRESENIUS KABI
LUPIN LTD.
SANDOZ
SUN PHARMACEUTICAL INDUSTRIES LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
VIATRIS INC.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us